![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > France
Please find below persons from France.Total search results: 1296 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Satola, Margaux (Eurosanté 201704 Business Development Manager) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Saulnier, Monique (Sofinnava Partners 201509 Managing Partner + CFO) | Managing Partner (investment firm) | Sofinnova (Group) | Île-de-France (region) |
| Saunders, Michael (Elitech Group 200808 VP Marketing + BusDev) | Business Development Manager / Strategy Manager | Elitech (Group) | Île-de-France (region) |
| Sautrau, Romain (CEA Industrie 202107 Investment Director at Supernova Invest) | Investment Manager | CEA (Group) | Île-de-France (region) |
| Sauvaigo, Sylvie (LXRepair 202101– CSO + Founder before CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | LXRepair SAS | Auvergne-Rhône-Alpes (region) |
| Scemama, Isabelle (Axa 202107 Global Head of AXA IM Alts & CEO of AXA IM Real Assets) | President/Director/Head Business Group/Unit/Division | Axa (Group) | Île-de-France (region) |
| Schaettel, Nicolas (HypnoVR 202112 CEO + Co-Founder) | Chief Executive Officer (CEO) | HypnoVR SAS | Grand Est (Great East) (region) |
| Scheer, Alexander (Erytech 201610– CSO before Pierre Fabre + Merck Serono + Serono) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
| Schilansky, David (Home Biosciences 202111 CEO + Co-Founder before DBV Technologies + Lysogene) | Chief Executive Officer (CEO) | Home Biosciences (Group) | Île-de-France (region) |
| Schmidt, John A., Jr. (Jack) (Alnylam 200810– CSO before Sanofi-Aventis) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Alnylam (Group) | Massachusetts (federal state) |
| Schmitt, Jean (Jolt Capital 2011– Founder + Managing Partner before Sofinnova) | Managing Partner (investment firm) | Jolt Capital SAS | Île-de-France (region) |
| Schmitt, Laurent (L’Oréal 201812 President of BOLD Business Opportunities for L’Oréal Development) | President/Director/Head Business Group/Unit/Division | L’Oréal (Group) | Île-de-France (region) |
| Schmitt-dos Santos, Juliette (Andrew Lloyd & Associates 2012– Director joined 2002) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | Île-de-France (region) |
| Schneiderman, Daniel (Biophytis 201907 CFO) | Chief Financial Officer (CFO) | Biophytis (Group) | Île-de-France (region) |
| Schoreel, Anaïs (Eurasanté 201709 Business Development Manager) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Schrenk, U. Marion (Servier 201604 Head Global Medical Strategy Oncology) | Corporate Strategy Manager | Servier (Group) | Île-de-France (region) |
| Schweitzer, Nicolas (77 Foods 202201 CEO + Co-Founder) | Chief Executive Officer (CEO) | 77 Foods SAS (d/b/a La Vie Foods) | Île-de-France (region) |
| Schweizer, Liang (HiFiBio 201708– CEO + Co-Founder before Harbour BioMed + Sanofi Head of Asian Cancer Research) | Chief Executive Officer (CEO) | HiFiBio (Group) | Île-de-France (region) |
| Schwich, Pierre (Pharnext 201602– CFO before Cellectis + 3i + Siparex + Next Venture + Corning + Danone + HP) | Chief Financial Officer (CFO) | Pharnext SAS | Île-de-France (region) |
| Scott, Robert A. (Cerenis 200801– CMO before AtheroGenics before Pifzer) | Chief Medical Officer (CMO) | Abionyx (Group) | Occitanie (Occitania) (region) |
| Sèche, Edouard (VitamFero 201107 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | VitamFero S.A. | Île-de-France (region) |
| Sedel, Frédéric (MedDay 2011– CEO + Co-Founder) | Chief Executive Officer (CEO) | MedDay Pharmaceuticals SAS | Île-de-France (region) |
| Ségard, Lionel (Quantum Genomics 201707 CEO + Chairman) | Chief Executive Officer (CEO) | Quantum Genomics (FR) (Group) | Île-de-France (region) |
| Seghezzi, Graziano (Sofinnova Partners 200806 Partner) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Séjourné, Florence (Boehringer 202210– CEO of Aurobac Therapeutics before Da Volterra + Genfit) | Chief Executive Officer (CEO) | Boehringer Ingelheim (Group) | Auvergne-Rhône-Alpes (region) |
| Selig, Luc (Cellectis 201105 VP Sales + Marketing at Cellectis Bioresearch) | Sales Manager / Marketing Manager | Cellectis (Group) | Île-de-France (region) |
| Semerjian, Harout (Ipsen 201811 Chief Commerical Officer) | Chief Commercial Officer (CCO) | Ipsen (Group) | Île-de-France (region) |
| Senequier, Dominique (Adrian 201309 CEO) | Chief Executive Officer (CEO) | Ardian (Group) | Île-de-France (region) |
| Sergeant, Aurore (Mérieux 201602 Media Relations at bioMérieux) | Public Relations Manager / Investor Relations Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Serra, Vincent (Wittycell 201402 CEO + CSO + Co-founder) | Chief Executive Officer (CEO) | Abivax (Group) | Grand Est (Great East) (region) |
| Sesini, Frédéric (Servier 201601 EVP International Operations) | President/Director/Head Business Group/Unit/Division | Servier (Group) | Île-de-France (region) |
| Seta, Jean-Philippe (Servier 2003–201310 CEO joined Servier 1984 LEFT 201310) | Chief Executive Officer (CEO) | Servier (Group) | Île-de-France (region) |
| Sharma, Ashwani (Eurosafe Sarl 201807 General Manager) | General Manager (management) | Eurosafe S.àr.l. | Bretagne (Britanny) (region) |
| Sharp, Dan (Valneva 202104 Government + Public Affairs Manager) | Public Relations Manager / Investor Relations Manager | Valneva (Group) | Pays de la Loire (region) |
| Siddiqi, Naveed (Novo Ventures 201912– Partner before 201312– Partner at EdRIP BioDiscovery Funds + Phase4 Ventures) | Partner (venture partner) | Novo Group (Group) | Hovedstaden |
| Sidhoum, Marjorie (Domain Therapeutics 202205 Director of Business Development) | Business Development Manager / Strategy Manager | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Sieler, Miguel (Neovacs 201310 CEO before Bayer France CEO at Bayer since 1975) | Chief Executive Officer (CEO) | Neovacs (Group) | Île-de-France (region) |
| Silvente, Stéphane (Affichem 201508 CEO + Co-founder) | Chief Executive Officer (CEO) | Affichem (Group) | Occitanie (Occitania) (region) |
| Simon, Mathieu (Cellectis 2013–201803 COO joined 201204 as SVP Cellectis Group before Pierre Fabre + Wyeth RETIRED 3/18) | Chief Operating Officer (COO) | Cellectis (Group) | Île-de-France (region) |
| Simons, Frank (bioMérieux 200404 Global Product Manager Molecular Diagnostics) | Product Manager (personnel) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Sirat, Gabriel (Bioaxial 201311 CTO + Co-founder) | Chief Technology/Technical Officer (CTO) | Bioaxial SAS | Île-de-France (region) |
| Sixt, Bernhard (Edinburgh Molecular Imaging 201811– CEO before ImmunID + Agendia + Amersham + Nycomed) | Chief Executive Officer (CEO) | Edinburgh Molecular Imaging Ltd. (EM Imaging, EMI) | Scotland |
| Slaoui, Fatine (Alcen 202404 Head of Markeiting + Communications at Theryq) | Sales Manager / Marketing Manager | Alcen (Group) | France (region/state unspecified) |
| Smith, Kevin (Micropep Technologies 202107 Board Chairman) | Board member, non-executive | Micropep Technologies SAS | Occitanie (Occitania) (region) |
| Smolentseva, Olga (Bryan Garnier 202110 Equity Research Analyst Biotechnology) | Analyst (Financial / Industry) | Bryan, Garnier (Group) | Île-de-France (region) |
| Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma) | Chief Executive Officer (CEO) | Mithra Pharmaceuticals (Group) | Wallonia (region) |
| Sordet, Nicolas (Afyren 202108 CEO + Co-Founder before Link Securities + BNP Paribas + Société Générale) | Chief Executive Officer (CEO) | Afyren (Group) | Auvergne-Rhône-Alpes (region) |
| Sottil (before Filipowicz), Aneta (Andrea Partners 201804– before EdRIP before Norgine 2013 before Rothschild) | Investment Manager | Andera Partners (FR) | Île-de-France (region) |
| Sottilini, Frédéric (Carthera 202306 CEO) | Chief Executive Officer (CEO) | Carthera (Group) | Auvergne-Rhône-Alpes (region) |
| Soubeyran, Denis (France (govt) 201511– General Manager of LFB Biomedicaments joined 201009) | General Manager (management) | France (govt) | France (region/state unspecified) |
| Souêtre, Eric (Careventures 201011– Managing Partner + Labco 200904 CEO + Founder) | Chief Executive Officer (CEO) | Labco (Group) | France (region/state unspecified) |
| Soula, Gérard (Adocia 201201 CEO + co-founder also founder of Flamel Technologies) | Chief Executive Officer (CEO) | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
| Soula, Olivier (Adocia 2005 co-founder) | Company Founder | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
| Soula, Rémi (Argobio 202103– before Adocia + Avadel Pharmaceuticals) | Company Founder | Argobio SAS (BRIDGE collaboration) | Île-de-France (region) |
| Sourdive, David (Cellectis 200606 COO) | n. a. | Cellectis (Group) | Île-de-France (region) |
| Soustre, Jean-Marc (SE13 Advisors 202001 General Partner before 13advisory 201510 Partner) | Consultant (economic/technology) | SE13 Advisors S.a.r.l. Unipersonnelle | Provence-Alpes-Côte d’Azur (region) |
| Soyer, Eric (Erytech 201509– CFO + COO before EDAP-TMS) | Chief Financial Officer (CFO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
| Spagnol, Michel (Novasep 201306– CEO before Shasun + Rhodia) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
| Spagnol, Rémi (Supernova Invest 202306 Investment Director) | Investment Manager | CEA (Group) | Île-de-France (region) |
| Spedito-Jovial, Mélancolie (PathoQuest 202111 Marketing Manager) | Sales Manager / Marketing Manager | PathoQuest SAS | Île-de-France (region) |
| Spek, Hanspeter (sanofi-aventis 2007 Executive VP Pharmaceutical Operations) | n. a. | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Spence, Gavin (Nicox 201607 EVP Corporate Development) | Business Development Manager / Strategy Manager | Nicox (Group) | Provence-Alpes-Côte d’Azur (region) |
| Spurling, Darryl (GeneSystems 200809 CEO) | Chief Executive Officer (CEO) | Danaher (Group) | Bretagne (Britanny) (region) |
| Stamm, Alban (France (govt) 202001 Director Innovation at Bpifrance) | n. a. | France (govt) | Île-de-France (region) |
| Stauber, Jonathan (ImaBiotech 201206 CEO) | Chief Executive Officer (CEO) | ImaBiotech (Group) | Hauts-de-France (Upper France) (region) |
| Steens, Jean-Marc (Abivax 2015– CMO) | Chief Medical Officer (CMO) | Abivax (Group) | Île-de-France (region) |
| Steimer, Guillaume (Excelya 202007 Strategic Development Director) | Business Development Manager / Strategy Manager | Excelya (Group) | Île-de-France (region) |
| Stephan, Martin (Global Bioenergies 202310– CBO before Carbios + The Chemours Company + Du Pont) | Chief Business Officer (CBO) | Global Bioenergies (Group) | Île-de-France (region) |
| Straubinger, Helmut J. (Tricares 201603–2024032 CEO formerly JenaValve 200709 CEO RETIRED 3/24) | Chief Executive Officer (CEO) | Tricares (Group) | Île-de-France (region) |
| Stril, Arthur (Cellectis 202202 CBO) | Chief Business Officer (CBO) | Cellectis (Group) | Île-de-France (region) |
| Sun, Jian-Sheng (DNA Therapeutics 200704 CEO + Chairman) | Chief Executive Officer (CEO) | Onxeo (Group) | Île-de-France (region) |
| Surpal, Susheel (Ipsen 201109– CFO before Labco) | Chief Financial Officer (CFO) | Ipsen (Group) | Île-de-France (region) |
| Sztukowski, Edward (Buzz) (BioTrove 200712– SVP + CBO before bioMérieux before Remel before Abbott Diagnostics Div) | Chief Business Officer (CBO) | Thermo Fisher (Group) | Massachusetts (federal state) |
| Tabah-Fisch, Isabelle (GamaMabs Pharma 201809 CMO) | Chief Medical Officer (CMO) | GamaMabs Pharma S.A. | Occitanie (Occitania) (region) |
| Tabouis, Stéphanie (Publicis 201411) | Public Relations Manager / Investor Relations Manager | Publicis (Group) | Île-de-France (region) |
| Takacs, Laszlo (BioSystems International 200512 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
| Tambourin, Pierre (Genopole 1998– Chief Executive) | Chief Executive Officer (CEO) | Genopole (GIP Genopole) | Île-de-France (region) |
| Tangy, Frederic (Institut Pasteur 201907 Director of Viral Genomics + Vaccination Unit + Founder of Oncovita SAS) | Researcher (university / research institute) | Institut Pasteur | Île-de-France (region) |
| Taverne, Cindy (Yucatan RP 201511) | Public Relations Manager / Investor Relations Manager | Yucatan S.a.r.l. (agence RP) | Île-de-France (region) |
| Tchelingerian, John (Promethera 201509– CEO before Silver Ocean Ventures + Neurotech + Diatos) | Chief Executive Officer (CEO) | Promethera (Group) | Belgium_o |
| Tempelaere, Vincent (Eveon 202301 CEO) | Chief Executive Officer (CEO) | Eveon SAS | France (region/state unspecified) |
| Templier, Alexandre (Quinten 202209 CEO + Co-Founder of Quinten) | Chief Executive Officer (CEO) | Quinten (Group) | Île-de-France (region) |
| Tharaud, Cécile (INSERM 201403– CEO of Inserm Transfert Initiative before CEO of Inserm Transfert) | Chief Executive Officer (CEO) | France (govt) | Île-de-France (region) |
| Thébault, Cécile (Sofimac Partners 201411 Investment Director) | Investment Manager | Sofimac Partners (FR) | Auvergne-Rhône-Alpes (region) |
| Theodosiou, Jason (Aureus Pharma 200612– CEO before COO before Elsevier MDL + Lion Bioscience) | Chief Executive Officer (CEO) | Reed Elsevier (Group) | Île-de-France (region) |
| Thérasse, Patrick (Servier 201703 Director of Clinical Development Oncology) | Clinical Research Manager | Servier (Group) | Île-de-France (region) |
| Therin, Michel (Affluent Medical 202401 Board Chair) | Board member, non-executive | Affluent Medical (Group) | Provence-Alpes-Côte d’Azur (region) |
| Therme, Jean (CEA 200912 Director of Technological Research) | n. a. | CEA (Group) | Île-de-France (region) |
| Thiam, Kader (genOway 201809 VP Transgenic Technologies) | n. a. | genOway (Group) | Auvergne-Rhône-Alpes (region) |
| Thiedey, Benoit (Alto Invest 201703 Investment Manager) | Investment Manager | Alto Invest (FR) | Île-de-France (region) |
| Thiroloix, Stéphane (AlgoTherapeutix 202303 CEO + Founder formerly Mayoly Spindler + Eucomed + Smith & Nephew + Ipsen) | Chief Executive Officer (CEO) | AlgoTherapeutix SAS (AlgoTx) | Île-de-France (region) |
| Thiry, Christian (Novasep 201308–201703 CFO before 12 years Stallergenes CFO GING 3/17) | Chief Financial Officer (CFO) | Novasep (Group) | Grand Est (Great East) (region) |
| This Saint-Jean, Isabelle (Genopole 201409– President) | President/Director/Head Business Group/Unit/Division | Genopole (GIP Genopole) | Île-de-France (region) |
| Thistle, Mary (Enterome 201707– Non-Executive Board Director main org Dimension Therapeutics before Cubist Pharma) | Chief Operating Officer (COO) | Ultragenyx (Group) | Massachusetts (federal state) |
| Thompson, Kristin (eureKARE 202208 CBO before Bioaster + Famar + DaVolterra) | Chief Business Officer (CBO) | eureKARE (Group) | Luxembourg (cl=4) |
| Tiennot-Herment, Laurence (Généthon 201509 President) | President/Director/Head Business Group/Unit/Division | French Myopathy Association (AFM) | Île-de-France (region) |
| Tierny, Dominique (OCR (FR) 201901 CEO + Founder) | Chief Executive Officer (CEO) | OCR (Oncovet Clinical Research) (FR) | Hauts-de-France (Upper France) (region) |
| Tillier, Bruno (Synthelis 201101– President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Synthelis (FR) | Auvergne-Rhône-Alpes (region) |
| Timmerman, Benedikt (Genticel 201304 CEO + Founder) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Tirouflet, Jean-Pierre (Biosystems International 200810 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
